Clinical efficacy and safety of cyproterone acetate in severe hirsutism: results of a multicentered Canadian study**Sponsored by the Canadian Fertility Research Association and funded by a grant-in-aid from Berlen Laboratories Limited, Canada.††The following collaborators participated in this study: Peter Garner, M.D., University of Ottawa; Barbara Cruckshank, M.D., University of Western Ontario; Youssef Ainmelk, M.D., University of Sherbrooke; Togas Tulandi, M.D., McGill University; Nacia Faure, M.D., Laval University; Arthur Leader, M.D., University of Calgary; Timothy Rowe, M.D., University of British Columbia; and Jerald Bain, M.D., University of Toronto.

Author:

Belisle Serge,Love Edgar J.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference19 articles.

1. Female hirsutism: pathophysiological considerations and therapeutic implications;Biffignandi;Endocr Rev,1984

2. Behandlung des hirsutismus cyproterone acetat. Dtsch Med Wochenschr 94:829, 1969;Hammerstein;Translated to German Med Monthly,1969

3. Pharmacology of antiandrogens;Neumann,1980

4. Aspects of androgen dependent events as studied by antiandrogens;Newmann;Recent Prog Horm Res,1970

5. The evaluation of the role of androgens in hirsutism and the use of a new antiandrogen cyproterone acetate for therapy;Ismail;J Clin Endocrinol Metab,1974

Cited by 59 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Directive clinique n° 444 : Hirsutisme : Évaluation et traitement;Journal of Obstetrics and Gynaecology Canada;2023-12

2. Guideline No. 444: Hirsutism: Evaluation and Treatment;Journal of Obstetrics and Gynaecology Canada;2023-12

3. A safety evaluation of current medications for adult women with the polycystic ovarian syndrome not pursuing pregnancy;Expert Opinion on Drug Safety;2020-11-05

4. No. 350-Hirsutism: Evaluation and Treatment;Journal of Obstetrics and Gynaecology Canada;2017-11

5. N o 350-Hirsutisme : évaluation et traitement;Journal of Obstetrics and Gynaecology Canada;2017-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3